$16.92 +0.07 (%) Avanir Pharmaceuticals Inc - NASDAQ

Dec. 22, 2014 | 12:33 PM

Partner Headlines

  1. UPDATE: Deutsche Bank Downgrades Avanir Pharmaceuticals, $17 Buyout Target 'Fair'

    Benzinga | Dec. 3, 2014 | 15:35PM EST
  2. Avanir Up On $3.5 Bil Offer

    IBD | Dec. 2, 2014 | 18:37PM EST
  3. Dow Ekes Out A New High

    IBD | Dec. 2, 2014 | 18:37PM EST
  4. Benzinga's M&A Chatter for Tuesday December 2, 2014

    Benzinga | Dec. 2, 2014 | 17:40PM EST
  5. Mid-Day Gainers From December 2: Digital Ally, Spansion And More

    Benzinga | Dec. 2, 2014 | 13:47PM EST
  6. Mid-Day Market Update: General Motors November US Auto Sales Surge; Vince Holding Shares Slide

    Benzinga | Dec. 2, 2014 | 13:30PM EST
  7. Avanir Stock Jumps On $3.5 Billion Otsuka Buyout

    IBD | Dec. 2, 2014 | 11:22AM EST
  8. Mid-Morning Market Update: Markets Open Higher; Cypress To Acquire Spansion In $4 Billion Deal

    Benzinga | Dec. 2, 2014 | 10:26AM EST
  9. Benzinga's Volume Movers

    Benzinga | Dec. 2, 2014 | 10:16AM EST
  10. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 2, 2014 | 10:02AM EST
  11. Morning Market Movers

    Benzinga | Dec. 2, 2014 | 09:38AM EST
  12. Stock Market Today: Futures Up; Energy Mixed, Gold ETFs Fall

    IBD | Dec. 2, 2014 | 08:56AM EST
  13. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 2, 2014 | 08:08AM EST
  14. Micro-Cap ETF And The Falling Greenback

    Benzinga | Oct. 13, 2014 | 17:28PM EST
  15. Morning Market Movers

    Benzinga | Sep. 24, 2014 | 09:40AM EST
  16. Dow Down 0.6%; CarMax Shares Fall After Q2 Results

    Benzinga | Sep. 23, 2014 | 15:13PM EST
  17. Ascena Retail Drops On Downbeat Earnings; CF Industries Shares Gain

    Benzinga | Sep. 23, 2014 | 12:43PM EST
  18. Markets Mixed; Carnival Profit Tops Street View

    Benzinga | Sep. 23, 2014 | 11:20AM EST
  19. Morning Market Losers

    Benzinga | Sep. 23, 2014 | 09:47AM EST
  20. Morning Market Losers

    Benzinga | Sep. 16, 2014 | 09:49AM EST
  21. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 16, 2014 | 08:11AM EST
  22. Avanir Pharmaceuticals

    IBD | Sep. 15, 2014 | 18:53PM EST
  23. Technology Stocks Down As Rest Of The Market Starts Week Flat

    Benzinga | Sep. 15, 2014 | 17:15PM EST
  24. Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge

    Benzinga | Sep. 15, 2014 | 15:40PM EST
  25. NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer

    Benzinga | Sep. 15, 2014 | 13:24PM EST
  26. Midday Gainers From September 15 - RadioShack Corporation, Rewalk Robotics Ltd And More

    Benzinga | Sep. 15, 2014 | 12:32PM EST
  27. Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion

    Benzinga | Sep. 15, 2014 | 11:26AM EST
  28. Benzinga's Volume Movers

    Benzinga | Sep. 15, 2014 | 10:17AM EST
  29. Morning Market Movers

    Benzinga | Sep. 15, 2014 | 09:42AM EST
  30. Avanir Pharmaceuticals Announces Positive Phase II Trial Results For AVP-923 In Treatment Of Agitation In Patients With Alzheimer's Disease

    Benzinga | Sep. 15, 2014 | 08:33AM EST
  31. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 11, 2014 | 10:06AM EST
  32. Events for the Week of Sept. 8-12

    Benzinga | Sep. 10, 2014 | 14:34PM EST
  33. U.S. Stocks Rise; Palo Alto Networks Shares Surge On Upbeat Revenue

    Benzinga | Sep. 10, 2014 | 12:48PM EST
  34. Avanir Pharmaceuticals Announces Initiation Of Phase II Study of AVP-786 For The Adjunctive Treatment Of Major Depressive Disorder

    Benzinga | Aug. 26, 2014 | 09:02AM EST
  35. Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of Major Depressive Disorder

    Benzinga | Jul. 21, 2014 | 09:17AM EST
  36. AVANIR Pharma Offers Three Presentations for AVP-825 for Acute Treatment of Migraine

    Benzinga | Jun. 24, 2014 | 08:32AM EST
  37. Morning Market Movers

    Benzinga | Jun. 10, 2014 | 09:39AM EST
  38. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 10, 2014 | 08:04AM EST
  39. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 2, 2014 | 08:30AM EST
  40. Avanir Pharmaceuticals Announces Data Presentation of Central Nervous System (CNS) Therapeutics Franchise at American Academy of Neurology Meeting

    Benzinga | Apr. 28, 2014 | 08:34AM EST
  41. Morning Market Movers

    Benzinga | Mar. 26, 2014 | 09:44AM EST
  42. UPDATE: Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine

    Benzinga | Mar. 26, 2014 | 09:01AM EST
  43. Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors

    Benzinga | Mar. 19, 2014 | 16:00PM EST
  44. Avanir Pharmaceuticals Announces Submission of New Drug Application for AVP-825 for the Acute Treatment of Migraine

    Benzinga | Jan. 30, 2014 | 09:01AM EST
  45. Mid-Afternoon Market Update: Markets Falling as Smith & Wesson Continues to Rise on Earnings

    Benzinga | Dec. 11, 2013 | 16:02PM EST
  46. Mid-Day Market Update: Smith & Wesson Gains On Upbeat Profit; LabCorp Shares Decline

    Benzinga | Dec. 11, 2013 | 12:29PM EST
  47. Mid-Morning Market Update: Markets Fall; Joy Global Profit Misses Estimates

    Benzinga | Dec. 11, 2013 | 11:37AM EST
  48. Morning Market Losers

    Benzinga | Dec. 11, 2013 | 10:05AM EST
  49. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 11, 2013 | 08:34AM EST
  50. Benzinga's Top Downgrades

    Benzinga | Dec. 11, 2013 | 08:13AM EST
Trading Center